ArticleMolecular therapy. Methods & clinical development2023

Establishment of UGT1A1-knockout human iPS-derived hepatic organoids for UGT1A1-specific kinetics and toxicity evaluation.

Tomohiro Shintani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.